Compound Summary


  Compound Information
 tolazamide

Compound Name:

tolazamide

Compound CID:

5503

Synonyms:

tolazamide

1156-19-0

Tolinase

Norglycin

Tolanase

More...

Iupac Name:

1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea

InChI:

InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)

InChIKey:

OUDSBRTVNLOZBN-UHFFFAOYSA-N

Canonical Smiles:

CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2

Isomeric Smiles:

CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2

Molecular Weight:

311.4

Molecular Formula:

C14H21N3O3S

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 tolazamide

Molecular Weight:

311.4

Molecular Formula:

C14H21N3O3S

Hydrogen Bond Donor Count:

2

Hydrogen Bond Acceptor Count:

4

Rotatable Bond Count:

3

Heavy Atom Count:

21

Complexity:

431

  Synonyms
 tolazamide

tolazamide tolazamide

tolazamide

1156-19-0

Tolinase

Norglycin

Tolanase

Diabewas

Tolazolamide

Tolazamida

Tolazamidum

1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea

N-(p-Toluenesulfonyl)-N-hexamethyleniminourea

U-17835

4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide

NCI-C03327

1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea

1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea

U 17835

CCRIS 591

NSC-70762

UNII-9LT1BRO48Q

Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl-

EINECS 214-588-3

Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)-

BRN 1323565

Benzenesulfonamide, N-(hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methyl-

9LT1BRO48Q

MLS000028534

CHEBI:9613

N-(azepan-1-ylamino)carbonyl-4-methylbenzenesulfonamide

N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide

NSC70762

N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide

Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-

1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea

NCGC00016009-10

SMR000058290

CAS-1156-19-0

DSSTox_CID_1358

DSSTox_RID_76105

DSSTox_GSID_21358

Tolazamidum INN-Latin

Tolazamida INN-Spanish

1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane

Tolinase (TN)

HSDB 3192

SR-01000003105

NSC 70762

1-(Azepan-1-ylamino)carbonyl-4-methylbenzenesulfonamide

1-({(4-methylphenyl)sulfonylamino}carbonyl)aminoazepane

Ronase

(azaperhydroepinylamino)-N-(4-methylphenyl)sulfonylcarboxamide

AI3-50826

N-{(hexahydro-1H-azepin-1-yl)-aminocarbonyl}-4-methylbenzenesulfonamide

Prestwick_865

Tolazamide USAN:USP:INN:BAN:JAN

Spectrum_001269

Opera_ID_1740

Prestwick0_000554

Prestwick1_000554

Prestwick2_000554

Prestwick3_000554

Spectrum2_001449

Spectrum3_001473

Spectrum4_000240

Spectrum5_001204

Lopac-T-2408

CHEMBL817

Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl-

T 2408

3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea

NCIOpen2_008361

CBiol_001918

Lopac0_001195

Oprea1_061180

SCHEMBL34417

BSPBio_000627

BSPBio_001505

BSPBio_003025

KBioGR_000225

KBioGR_000939

KBioSS_000225

KBioSS_001749

Tolazamide (JAN/USP/INN)

1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea

5-20-04-00062 (Beilstein Handbook Reference)

MLS001076161

DivK1c_000212

SPECTRUM1501201

SPBio_001317

SPBio_002548

BPBio1_000691

GTPL6847

WLN: T7NTJ AMVMSWR D1

DTXSID3021358

BCBcMAP01_000061

HMS500K14

KBio1_000212

KBio2_000225

KBio2_001749

KBio2_002793

KBio2_004317

KBio2_005361

KBio2_006885

KBio3_000449

KBio3_000450

KBio3_002525

ZINC57512

NINDS_000212

Bio1_000204

Bio1_000693

Bio1_001182

Bio2_000225

Bio2_000705

HMS1361L07

HMS1569P09

HMS1791L07

HMS1921P19

HMS1989L07

HMS2089L10

HMS2092L09

HMS2096P09

HMS2232L21

HMS3259O18

HMS3263P11

HMS3369L04

HMS3402L07

HMS3713P09

Pharmakon1600-01501201

BCP23550

HY-B0920

Tox21_110281

Tox21_201507

Tox21_300416

Tox21_501195

2761AH

CCG-39178

MFCD00083504

NSC758149

SBB058190

AKOS015913823

N-(Hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methylbenzenesulfonamide

Tox21_110281_1

ACN-053046

DB00839

KS-1438

LP01195

MCULE-9265102499

NC00590

NSC-758149

SDCCGSBI-0051162.P004

Benzenesulfonamide, {N-(hexahydro-1H-azepin-1-yl)aminocarbonyl-4-methyl-}

IDI1_000212

IDI1_033975

NCGC00016009-01

NCGC00016009-02

NCGC00016009-03

NCGC00016009-04

NCGC00016009-05

NCGC00016009-06

NCGC00016009-07

NCGC00016009-08

NCGC00016009-09

NCGC00016009-11

NCGC00016009-12

NCGC00016009-13

NCGC00016009-14

NCGC00016009-15

NCGC00016009-16

NCGC00016009-17

NCGC00016009-19

NCGC00016009-24

NCGC00023701-03

NCGC00023701-04

NCGC00023701-05

NCGC00023701-06

NCGC00023701-07

NCGC00023701-08

NCGC00023701-09

NCGC00023701-10

NCGC00254501-01

NCGC00259058-01

NCGC00261880-01

1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea

SBI-0051162.P003

AB00052247

EU-0101195

FT-0675268

ST51015133

SW196991-3

C71499

D00379

AB00052247-15

AB00052247_16

AB00052247_17

A921617

1-(azepan-1-yl)-3-(4-methylbenzene)sulfonylurea

Q7814101

SR-01000003105-2

SR-01000003105-4

SR-01000003105-5

SR-01000003105-8

W-109110

BRD-K32164935-001-06-8

BRD-K32164935-001-17-5

BRD-K32164935-001-28-2

F2173-1137

1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea

1-(((4-Methylphenyl)sulfonylamino)carbonyl)aminoazepane #

Tolazamide, United States Pharmacopeia (USP) Reference Standard

Benzenesulfonamide, N-(hexahydro-1-azepinyl)aminocarbonyl-4-methyl-

  Experimental Data
 tolazamide

Species Dosage Unit CG Lifespan(AVG/MED days) TG Lifespan(AVG/MED days) Lifespan Change(AVG/MED%) CG Lifespan(MAX days) TG Lifespan(MAX days) Lifespan Change(MAX%) Significant Strain Gender PubMed Active Label
Caenorhabditis elegans 33 umol/L 3 NS N2 24134630 Inactive
  Experimental Data Visualization
 tolazamide

  Statistics Data
 tolazamide

Species Lifespan Change(AVG/MED%) Lifespan Change(MAX%) Count Reference Count Data point
Caenorhabditis elegans 3 1 1
  Statistics Data Visualization
 tolazamide